ANDA 203994, held by Northland. Fludeoxyglucose F-18.
As of Nov 16, 2026, ANDA 203994 (Fludeoxyglucose F18), held by Northland, was first approved by FDA on Feb 4, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 4, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fludeoxyglucose F184-500mCi/ML ยท injectable;intravenous | Fludeoxyglucose F-18 | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters